Pacer Advisors, Inc. Esperion Therapeutics, Inc. Transaction History

Pacer Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$19.4 - $28.71 $49,896 - $73,842	-2,572 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$25.12 - $36.89 $41,799 - $61,384	-1,664 Reduced 39.28%	2,572 $72,000
Q4 2020 Jan 20, 2021	BUY	$24.2 - $35.76 $44,044 - $65,083	1,820 Added 75.33%	4,236 $110,000
Q3 2020 Oct 19, 2020	BUY	$31.18 - $52.71 $75,330 - $127,347	2,416 New	2,416 $90,000
Q4 2018 Feb 13, 2019	SELL	$36.99 - $59.11 $188,279 - $300,869	-5,090 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$40.74 - $51.41 $207,366 - $261,676	5,090 New	5,090 $226,000
Q1 2018 May 14, 2018	SELL	$65.94 - $80.76 $92,316 - $113,064	-1,400 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$43.47 - $67.43 $60,858 - $94,402	1,400	1,400 $92,000

215

129M

1.78M

1.27M

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $110M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.